Correlation Between Bank of America and Pharma Bio

Can any of the company-specific risk be diversified away by investing in both Bank of America and Pharma Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of America and Pharma Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bank of America and Pharma Bio Serv, you can compare the effects of market volatilities on Bank of America and Pharma Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of America with a short position of Pharma Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of America and Pharma Bio.

Diversification Opportunities for Bank of America and Pharma Bio

-0.83

Correlation Coefficient

Bank of America  Pharma Bio

Pay attention - limited upside

The 3 months correlation between Bank and Pharma is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding Bank of America and Pharma Bio Serv in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharma Bio Serv and Bank of America is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of America are associated (or correlated) with Pharma Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharma Bio Serv has no effect on the direction of Bank of America i.e., Bank of America and Pharma Bio go up and down completely randomly.

Pair Corralation between Bank of America and Pharma Bio

Considering the 90-day investment horizon Bank of America is expected to generate 0.23 times more return on investment than Pharma Bio. However, Bank of America is 4.31 times less risky than Pharma Bio. It trades about 0.17 of its potential returns per unit of risk. Pharma Bio Serv is currently generating about 0.0 per unit of risk. If you would invest  3,888  in Bank of America on September 16, 2024 and sell it today you would earn a total of  679.00  from holding Bank of America or generate 17.46% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Bank of America  vs.  Pharma Bio Serv

Bank of America

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Bank of America are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Bank of America exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pharma Bio Serv

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pharma Bio Serv has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Pharma Bio is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Bank of America and Pharma Bio

The main advantage of trading using opposite Bank of America and Pharma Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of America position performs unexpectedly, Pharma Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharma Bio will offset losses from the drop in Pharma Bio's long position.

The idea behind Bank of America and Pharma Bio Serv pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.